Thomas J. Rice
Representative Legal Matters
Represented leading global health care company in its offer and sale of USD 1 billion of Senior Notes.
Represented leading independent New York based ETF Sponsor in sale of its business to non-US fund buyer.
Represented European food ingredients company in connection with the acquisition of algae based product business from a US public company.
Represented South Asia based satellite television company in its USD 273 million initial public offering on the Nasdaq Stock Market (conducted via an exchange offer with a SPAC).
Represented a leading US publishing and education company in a USD 575 million asset sale transaction with a US public company strategic acquiror.
Represented a leading sovereign wealth fund investor in multiple fund investments with leading global private equity fund sponsors.
Represented sponsor in formation of event driven, special purpose shareholder activist funds and in two resulting proxy contests.
Represented NYSE listed industrial company in a USD 550 million asset sale transaction with a US public company strategic acquiror.
Represented two bulge bracket investment banks, Joint Lead Managers and Initial Purchasers on the offer and sale of $500 million Step Up Subordinated Callable Notes due 2017, offered by a Turkish finance company organized at the instruction of a major Turkish bank.
Represented a leading US publishing and education company in multiple acquisitions and divestitures for its magazine, book distribution and education segments.
Represented a leading US publishing and education company in a USD 150 million equity self-tender offer conducted under US federal securities laws.
- New York~United States (1986)
- New York University School of Law (J.D.) (1985)
- Yale University (B.A., summa cum laude, Phi Beta Kappa) (1982)
- Co-Author, "United States: SEC proposes rules for further disclosure and enhanced investor protections regarding SPACs," Baker McKenzie Client Alert, 5 April 2022
- Co-author, "New Direction in SEC Policy Expands Disclosure Requirements Foreign Issuers Face in the United States," The Metropolitan Corporate Counsel, 2001